Who is Who

Who is Who
Biographic Information
Fiona Adshead, Dr. (1962), British; Director of
the World Health Organization's Department of
Chronic Diseases and Health Promotion; he holds
degrees in Medicine, Public Health and
Psychology; until January 2008 Dr. Adshead was
the Deputy Chief Medical Officer and Director
General for the Health Improvement Directorate in
the Department of Health for England where she
led the development of national policy and
programmes in key public health areas and
worked with colleagues across government on
developing healthy public policy.
Wolfgang Ahrens, Prof. Dr. rer. nat.; Deputy
Director, Bremen Institute of Prevention Research
and social Medicine (BIPS), University Bremen;
Head, Department Epidemiological Methods and
Etiologic Research; having finished his biology
studies in 1985 he worked as scientific assistant
in numerous epidemiologic studies with focus on
work- and environment-related cancer. In the
years 1995-1998 he established the working
group Epidemiology at the Institute for Medical
Informatics,
Biometry
and
Epidemiology,
University Clinic Essen. After having earned his
doctorate with a dissertation on "Retrospective
assessment of occupational exposure in
epidemiological case- control studies" he
established
the
cross
sectional
division
Epidemiological Methods and Field Work at the
BIPS. From 1998-2003 he was Head of the
division. In 2000 he qualified as professor for
Epidemiology and Public Health. His research
activities centre on the field of aetiology of cancer
focussing
on
environmental
factors
and
occupational exposures, he also conducts
research to the use of secondary data in research
of pharmaceutical drug safety as well as primary
prevention and evaluation. Currently he coordinates the largest Europe-wide intervention
study on overweight, obesity and further health
effects in children induced by diet, lifestyle and
social factors (www.idefics.eu); memberships
include: International Society of Behavioural
Nutrition and Physical Activity (ISBNPA),
International Epidemiological Association (IEA),
German Society for Epidemiology.
Tit Albreht, Dr. (1961), Slovenian; Medical
Doctor, Doctorate of Science in Health Services
Research (Erasmus University Rotterdam), Head
of the Centre for Analyses of Health Systems,
Institute of Public Health of the Republic of
Slovenia, Researcher in the field of health
services research, health policy and health
systems research, member of the Scientific
Committee of EUPHA, member of Academy
Health, member of the Slovenian Preventive
Medicine Society – currently also member of its
Board, member of the Health Council of the
Ministry of Health of Slovenia. He acts as a
reviewer of several scientific journals and of
projects submitted for financing to the European
Commission.
Rifat Atun, Prof.; joined the Executive
Management Team of The Global Fund to Fight
AIDS, Tuberculosis and Malaria as the Director of
Strategy, Performance and Evaluation Cluster in
September 2008. Prior to this, he was Professor
of International Health Management and Director
of the Centre for Health Management at the
Imperial College London, in addition to teaching
on MBA and MPH programmes. At Imperial
College, Rifat founded and led the Centre for
Health Management: a multidisciplinary research
group which explored how contextual and health
systems factors influence the adoption and
diffusion of communicable disease control
programmes. He has worked extensively with the
World Bank, World Health Organization, and the
UK Department for International Development in
Europe, Latin America, Central Asia and the
Middle East on health systems reform
programmes. He was member of the Strategic
Technical Advisory Group (STAG) of the World
Health Organization for Tuberculosis and chaired
the WHO Task Force on Health Systems and
Tuberculosis Control. Until recently, he was a
Member of the Advisory Committee for WHO
Research Centre for Health Development in
Japan.
Clemens-Martin Auer, Dr., Director General,
Federal Ministry of Health, Austria.
Ian Banks, Prof. BSc. BAO. BCh. MB. MSc. PhD;
while working part-time as a family doctor and
A&E officer in Belfast, Ian also represents doctors
for the British Medical Association as a member of
Council for the UK and awarded a BMA accolade,
the Association Medal. He worked on the
Developing Patient Partnerships (DPP formerly
Doctor Patient Partnership) for six years. He is the
official spokesman on men’s health issues for the
BMA, President of the European Men’s Health
Forum and the England & Wales Men’s Health
1
Forum, vice president of the International Society
for the Study of Men’s Health, deputy editor of the
Men’s Health Journal and for six years the
medical editor for The Men’s Health Magazine.
The BBC book ‘The Trouble with Men’ was written
by Ian in 1996 to accompany the television series
of the same name. It was followed by Men’s
Health, The Good Patient Guide, The Children's
Health Guide and the 50th NHS Anniversary book
from the NHSE/HEA “The Home Medicine Guide”.
He is also the author of the NHS Direct
Healthcare Guide and Web site. Ian was
appointed visiting professor of men’s health in
Europe by Leeds Metropolitan University in 2005
and awarded the Royal Society of Health Gold
Medal for public health in 2007. The City of
Vienna and the International Society of Men’s
Health honoured Ian with their award for public
health in September 2007.
Enis Baris; Director, Division of Country Health
Systems WHO Regional Office for Europe.
Nicola Bedlington, (1965) British; studied
business and human resource management in the
UK. Nicola was the first Director of the European
Disability Forum, a Brussels-based umbrella
organisation uniting European disability NGOs to
advocate for the human rights and inclusion of
disabled citizens in Europe (1996 to 1999), and
prior to this she headed the NGO unit within
HELIOS, a European Commission Action
Programme promoting equal opportunities for
disabled people (1991-1996). From 2004 to mid
2006, she was mandated to lead the Environment
and Schools Initiatives Secretariat (ENSI), an
international government-based network set up by
OECD focussing on innovation, action research
and policy development in the field of Education
for Sustainable Development. She has also
worked as an independent consultant/evaluator,
specialising in European social and development
policy and health advocacy. Nicola became the
European Patients’ Forum first Executive Director
in June 2006.
Nicola Benge, (1962), British; is Director Health
improvement and Public Health with NHS
Birmingham East and North. She is a Fellow of
the Faculty of Public Health and by professional
background is a nurse midwife and health visitor.
Areas of special interest include deprivation and
its links to reduced life expectancy and mental
health and exclusion. In 2007 she lead a
programme which saw 10,000 men be screened
for cardiac risk within a six month period with the
aim of identify high risk individuals and providing
early intervention.
Christina Bergdahl, (1942) Swedish; former
employment officer, retired, member and working
as a volunteer for Blood Cancer Association.
Member of the organising committee for Patient &
Family Day during EBMT (European Group for
Blood and Marrow Transplantation) which was
arranged in Göteborg, Sweden March 2009.
Member of an advisory group assisting the
production of the guide “Understanding Health
Technology Assessment (HTA)”.
Phillipe Beutels, Prof., Scientific Director, Centre
for Health Economics Research & Modeling
Infectious Diseases (CHERMID), Vaccine &
Infectious Disease Institute, University of Antwerp.
Jerome Boehm; economist, he is working in the
European Commission, in the Health and
Consumers Directorate General, after having
worked as a consultant in the private sector. His
work objectives are the following: to promote EU
cooperation on HTA in Europe, to contribute to
pharma/ medical devices initiatives launched with/
by the Enterprises Directorate General, to
promote health investment in Europe, notably
through the use of the structural funds of the EU
cohesion policy.
Paolo Bonanni, Prof. MD; he graduated in
Medicine and Surgery (MD) in 1985 and got two
specializations in Hygiene and Preventive
Medicine at the University of Genoa, Italy.
Associate Professor (1992-2000) and since 2000
Full Professor of Hygiene in the Faculty of
Medicine, University of Florence. His scientific
activity has covered the epidemiology and
prevention of infectious diseases, particularly viral
hepatitis, diphtheria, tetanus, pertussis, influenza,
measles, rubella, varicella, and, most recently,
bacterial invasive diseases and HPV, including
clinical trials and economic evaluation of
vaccination strategies. He has been a member of
the National Vaccination Commission of the Italian
Ministry of Health, and he acts as an expert
consultant for the European Centre for Disease
Prevention and Control (ECDC) based in
Stockholm. He is standing adviser of the Viral
Hepatitis
Prevention
Board
(VHPB),
an
international independent committee of experts in
viral hepatitis prevention. He is the author or coauthor of 200 scientific papers published in
international and national journals. He received
several grants from the Italian Ministry of
University on projects regarding vaccine-
2
preventable infections and was responsible of a
research unit in 3 EU-funded projects named
ANTRES (antibiotic resistance in Latin America),
EURO-HEPNET (feasibility of a EU network for
surveillance of vaccine-preventable hepatitis) and
VACSATC (vaccine safety, attitudes and training).
Paolo Bonanni is the Director of the University of
Florence Post-Graduate Course on 'Vaccines and
Vaccination Strategies', established in 2001, 9
editions of which have been followed by over 450
Italian MDs (mostly public health doctors and
paediatricians).
John Bowis, MA (1945), British; Member of the
European Parliament; EEP Group Coordinator
and Spokesman on Environment and Health,
Member of the Development Committee, Vice
President of the Joint Parliamentary Assembly of
MPs from Africa, Caribbean and Pacific and
Europe (ACP), EP Delegation for Palestine (20049) and Central Asia (1999-2004); Rapporteur for
the Parliament on Food Safety, Health and
Enlargement, Professional Qualifications, Health
and Poverty in Developing Policy, the European
Centre for Disease Prevention and Control,
Patient Mobility, Mental Health, Neglected
Diseases and Cross Border Health; former
Minister for Health & Social Services and former
Minister for Transport (London and Road Safety),
1987-1997 Member of UK Parliament, 1989-1993
Parliamentary Private Secretary Environment and
Welsh Office; 1997-1999 International Policy
Adviser to the WHO working in support of
campaigns on Mental Health and Epilepsy.
David Boyd; European Government and Public
Affairs Manager, GE Healthcare.
Nick Boyd; joined the Department of Health (DH)
in the UK in 1977 after studying History and
German at Oxford University, and teaching in
Germany. He held a number of policy jobs in DH
in public health, health and social care. He went
on secondment to the German Ministry of Health
in 1981 and again in 1991, working on EU policy
there. From 1993-6 he was secretary to the top
management board of DH, and from 1999-2006
he was Director of International Affairs. During
this time he oversaw the health component of the
UK’s Presidency of the EU. He was a member of
the EU High Level Committee on Health and the
High Level Group on Health Services and Medical
Care, and part of the UK delegation to the World
Health Assembly. Nick is now working
independently. He has advised the EU
Commission on their strategic approach to health,
and also assisted WHO (Euro) in their work on
health inequalities and the social determinants of
health.
Jeni Bremner, BA MSc RGN, (1960) British;
since March 2007 Director of the European Health
Management Association. She is a qualified nurse
and also holds an M.Sc in Health Education from
the University of London and an M.Sc in Health
Economics from the University of York. She has
substantial experience in the management and
design of health and social care systems both
working within health and social care systems and
as a consultant. She has many years political and
policy experience in the fields of public health,
health care and social care. Prior to taking up post
at EHMA she worked in the UK leading the
national local government policy agenda across a
number of areas including children services,
education, health, public health social care and
criminal justice.
Viola Bronsema, Dr. (1963), German; Managing
Director of BIO Deutschland, Germany’s
Biotechnology Industry Association. With its more
than 230 corporate members, the trade
association represents Germany’s innovative
biotechnology small and mid-seized enterprises
(SME). Viola Bronsema is member of EuropaBio’s
National Association Council. She earned her
Ph.D. at the Centre for Molecular Biology (ZMBH)
at the University of Heidelberg, Germany, before
training to become a Public Relations specialist.
Since then, she has held a number of different
leadership positions in prestigious pharmaceutical
and diagnostics corporations as Eli Lilly and
Roche Diagnostics.
Lucie Bryndová, (1981), Czech; economist
specializing in public finance and health
economics; chief advisor to the Minister of Health
of the Czech Republic (since 2006) and instructor
at the Faculty of Social Sciences, Charles
University in Prague. Previously worked for the
General Health Insurance Company of the Czech
Republic in the Department of Strategy (2005)
and served as an advisor for structural reforms of
public budgets to the Minister of Finance of the
Czech Republic (2004). She also participates in
the Health Reform.cz projects and has been
contributing to its proposal for the health care
reform in the Czech Republic.
James Buchan, Prof. (1958), British; Health
workforce
policy
and
human
resource
management; Research Professor, Queen
Margaret University, Edinburgh; Policy Associate,
WHO European Observatory; Visiting Professor,
3
University of Technology, Sydney. Associate
Fellow, Kings Fund, London.
Educational Affair, College of Medicine, National
Taiwan University.
Hartmut Buchow, Dr. (1950), German; studies of
laws and medicine in Berlin with doctoral theses in
virology; paediatrician by training, master's in
public
health
(Baltimore);
research
and
epidemiological work in Germany and U.S.A.;
seven years at the German Ministry of Health
before entering the European Commission in
1999; since 2002 at Eurostat, Luxembourg,
currently Head of Section Health & Safety
statistics with responsibility for implementing
Regulation no (EC) 1338/2008 on Community
health statistics on public health and health &
safety at work.
Emmanuel Chantelot, (1968) Belgian; Executive
Director
of
European
Biopharmaceutical
Enterprises (EBE), Brussels-based European
trade association of 65 biopharmaceutical
companies of all sizes and biotechnology arm of
EFPIA (European Federation of Pharmaceutical
Industries and Associations); Masters’ degrees in
Molecular Biology and Biotechnology, Free
University of Brussels; General Management
Program, Northwestern University, Chicago.
Julio E. Celis, Prof. (1941), Chilean; Ph.D. in
Biochemistry; Founding member of the European
Academy of Cancer Sciences; Chair of the Policy
Committee of the European CanCer Organisation
(ECCO); Scientific Director of the Institute of
Cancer Biology at the Danish Cancer Society;
President elect of the European Association for
Cancer Research (EACR), Member of the board
of the Organisation of European Cancer Institutes
(OECI); Generally recognised as one of the
founding fathers of proteomics; Editor-in-Chief of
Molecular Oncology; Member of the European
Molecular Biology Organisation (EMBO) and
Foreign Member of the Royal Danish Academy of
Sciences and Letters; to date author of about 300
publications, including 8 books.
Kalipso Chalkidou, Dr. (1976), Greek/British;
Medicine, Molecular Biology, Health Services
Research; head of the international programme
for the National Institute for Health and Clinical
Excellence (NICE) in London; visiting faculty,
Berman Institute of Bioethics, Johns Hopkins
Medical School (USA); honorary lecturer, London
School of Hygiene and Tropical Medicine (UK);
senior advisor, Centre for Medical Technology
Policy (USA); 2007-08 Harkness Fellow in Health
Policy and Practice (USA).
Shan-Chwen Chang, MD, PhD.; Deputy Minister,
Department of Health, Taiwan; Professor of
Medicine and Clinical Pharmacy, 1990-1992
Lecturer of Medicine and 1992-2000 Associate
Professor
of
Medicine, National
Taiwan
University; 1996-2009 Chief of Infectious Disease
Division, 2000-2008 Director of Infection Control
Team, 2002-2008 Director of Department of
Medical
Education,
2008-2009
Vicesuperintendent, National Taiwan University
Hospital; 2008-2009 Associate Dean for
Jorgo Chatzimarkakis, Dr. (1966) Germany;
after having obtained his German secondary
school diploma he started studying Political
Sciences in Bonn. In 1993 he graduated with a
Magister diploma and in 1995 he started his postgraduation studies including a research visit in
Oxford. There he was supervised by Lord
Dahrendorf. In June 2000 he received his doctor’s
degree. During his studies Dr. Chatzimarkakis
was actively engaged in politics. From 1993 to
1996, he was head of office of German MP and
minister of state at the Department of Foreign
Affairs, Helmut Schäfer. In July 1996 he got a job
in the Policy Planning Unit of the Department for
Foreign
Affairs.
In
January
1999
Dr.
Chatzimarkakis founded the business consultancy
polit data concept and in 2002 he initiated the Perl
Academy (European Management Training).
Before his election in 2004 as Member of the
European Parliament Dr. Chatzimarkakis was the
managing director of the academy. In June 2009
Dr. Chatzimarkakis was re-elected to European
Parliament. He is now representing the ALDE
Group as ALDE Coordinator in the Committee for
Budgetary Control. Furthermore, he is also
member of the Committee for Industry, Research
and Energy and substitute member in the
Committee for Environment, Public Health and
Food safety. Moreover, Dr. Chatzimarkakis will be
elected as chairman of the EP-Delegation for the
Former Yugoslav Republic of Macedonia
(FYROM). He is President of the German Hellenic
Business Association. In August 2009, he became
Vice-President of the World Hellenic InterParliamentary Association (WHIA). Since 2006 Dr.
Chatzimarkakis is member of the Pharmaceutical
Forum, a high level group designed to provide a
political mandate for relevant public health issues.
He launched the European Life Science Circle
(ELSC), a platform focussing on relevant issues
regarding life sciences and pharmaceuticals. Dr.
Chatzimarkakis has also been actively involved in
developing directives on a wide range of subjects,
4
most notably innovation issues (CIP), education
and research policies (EIT), and CO2 emission
reductions for the automotive industry (CARS 21).
He was nominated by Commissioner Günther
Verheugen to participate in the expert group that
supervises the implementation of CARS 21.
Michael S. Chen, Dr.; Vice-President and Chief
Financial Officer, Bureau of National Health
Insurance, Department of Health, Taiwan.
Shou-Hsia Cheng, Dr.; Deputy Minister,
Department of Health, Taiwan; Professor, College
of Public Health, National Taiwan University;
Ph.D., Health Policy and Resource Management,
School of Medicine, Yale University, USA; M.S.,
Institute of Public Health, College of Medicine,
National Taiwan University, Taiwan; Professor
and Director, Institute of Health Policy and
Management, College of Public Health, National
Taiwan
University,
Taiwan
(2006-2008);
Chairman, National Health Insurance Medical
Expenditure Negotiation Committee, Department
of Health, Taiwan (2005-2008).
Americo Cicchetti, Prof. (1969), Italian,
Professor of Management and Health Care Policy
and Management at the Faculty of Economics of
the Catholic University, Rome Italy. Director of the
Laboratory of Health Economics. Head of
Research of the Health Technology Assessment
Unit of the “A. Gemelli” University Hospital and
Network (Catholic University). Member of the
Executive Committee of the Health Technology
Assessment International.
John Clare, Managing
Communications Ltd.
Director,
LionsDen
Jan Willem Coebergh, Prof., Department of
Public Health, Erasmus MC, University Medical
Center Rotterdam.
Samuel Coenen, Dr., Postdoctoral Fellow,
Vaccine & Infectious Disease Institute - Centre for
General Practice, University of Antwerp - Campus
Drie Eiken.
Richard Coker, Prof. (1960), British; Medicine,
Public Health; Professor of Public Health,
Communicable Diseases Policy Research Group,
London School of Hygiene and Tropical Medicine,
London and Bangkok; heads a research team with
interests in health systems and communicable
diseases, notably influenza, TB and HIV in
particular in SE Asia.
Joan Cornet and Prat, (1950), Spanish; a
Technical Engineer in Metallurgy, and graduate in
Psychology. After working as a clinical
psychologist in a General Hospital in 1979, he
was elected mayor of Manresa. In 1988 he
became a civil servant in the European
Commission in Brussels and was later appointed
Secretary General of the Socialist Group in the
European Parliament in 1994. In June of 2004 he
was appointed General Secretary of the
Department of Health of the Government of the
Generalitat de Catalunya. In September 2005 the
Government entrusted him to start up the
“Bioregió of Catalonia” (Biotechnology) and since
January 2007 he has been Executive Chairman of
the Ticsalut Foundation, as Executive Chairman.
He is also a Professor of the UOC (Catalunya
Open University) and IL3 (International LongLearning-University of Barcelona).
Caroline Costongs, (1969) Dutch; MA in Public
Health, University of Maastricht, NL. Since 2000,
Programme Manager at EuroHealthNet, Brussels,
a leading European network of health promotion
and public health agencies. Responsible for
management of office activities and of several EC
co-funded projects on health inequalities, child
and family policy, health and social inclusion and
capacity building. She represents DETERMINE at
the EU Expert Group on Health Inequalities and
Social Determinants. Background activities:
Coordination of a national campaign on physical
activity promotion for young people at the
Netherlands Olympic Committee and Sports
Confederation.
Research
on
intersectoral
collaboration for health as part of an EU Research
Project (FP4) at the Liverpool John Moores
University, UK. Research at the National Capacity
Building Institute of the Ministry of Education in a
Latin-American country on the issue of special
education for children with specific health needs.
Agnes Cser, Dr.; Vice-President, SOC Section,
Member, European Economic and Social
Committee.
Maggie Davies, Principal Advisor, International
Health Inequalities, Department of Health,
England.
Antonio Di Giulio, Dr.; is currently Head of the
Unit Food, Health and Well-being in the
Commission Research Directorate General. He
started his professional career as an agricultural
economist with the United States Foreign
Agricultural Service- Department of Agriculture,
(FAS/USDA) in Rome, Italy, working primarily on
5
commodity and food products market analysis as
well as on scientific and regulatory aspects
including food safety and WTO trade issues. Prior
to his post with the European Commission, he
was Principal Administrator with the International
Centre for Advanced Mediterranean Agronomic
Studies, (CIHEAM) a Paris based intergovernmental organisation, linked to the OECD,
where he worked on policies and research
programmes on agricultural and food production
systems of the Mediterranean region. His duties
included
the
co-ordination
of
research
programmes, and the supervision of CIHEAM
Annual report on “development and agri-food
policies in the Mediterranean region”, and he was
also part of CIHEAM senior management
committee. He holds a Master degree in
Agricultural sciences and a specialized Master
degree in rural development, programmes and
projects. He has a doctoral degree in food
economics.
Christian Dierks, MD, JD (1960); Professor for
Health Services Research at Charité, Berlin is GP
and specialised attorney, partner of Dierks &
Bohle. His field is legal issues of statutory health
insurance, pharmaceutical and medical product
law, telemedicine and data protection in life
sciences. Secretary General of the German
Society for Medical Law, member of the American
Society of Law Medicine & Ethics and numerous
national and international scientific associations.
David P. Dolowitz, Dr. (1969), American;
Academic, Reader, University of Liverpool,
Department of Politics, Ph.D. University of
Strathclyde (UK); Member of the American
Political Science Association and the Mid-West
Political Science Association, Policy Advisor,
Research Consultant, Awarded, Lord Bryce Prize
in Comparative and International Politics;
Awarded, National Recognition Award For
Outstanding Contribution Toward Teaching and
Learning In Higher Education.
Barrie Dowdeswell, (1941), British; Economics;
Director of Research, European Centre for Health
Assets and Architecture, responsible for the
development and management of the Centre’s
portfolio of research activities and European
research network (primarily health related capital
planning and investment). Former Chief Executive
within the UK NHS, more recently association with
Australian University organisations and the
European Health Property Network.
Michael Drummond, Dr. (1948), British; Industrial
Metallurgy, Business Administration, Economics;
Professor of Health Economics, Centre for Health
Economics, University of York; researcher in the
economic evaluation of health technologies; Chair
of a Guidelines Review Panel for the National
Institute for Health and Clinical Excellence (NICE)
in the United Kingdom.
Wojciech Dziworski, DG SANCO, European
Commission.
Alexander M.M. Eggermont, Prof. (1952), Dutch;
Ph.D thesis on interferon in the treatment of
Cancer; President of the European CanCer
Organisation (ECCO); Full Professor and Head of
surgical oncology at the Erasmus University
Medical Centre Rotterdam, the Netherlands. He
served as EORTC (European Organisation for
Research and Treatment of Cancer) President,
EORTC Secretary General, Chair of the EORTC
Clinical Research Division and the EORTC
Melanoma Group and sat on the ASCO (American
Society of Clinical Oncology) Board. He received
numerous
awards
for
his
scientific
accomplishments: the Joseph Maisin Honorary
Chair at the Université Catholique Louvain,
Belgium; the Oswald van der Veken Award by the
National Academy of Sciences, Belgium; author of
over 400 peer-reviewed articles, monographs and
book chapters.
Cornelius Erbe, Dr. (1959), German, Medicine;
Senior Vice President and Member of the
extended Board of Deutsche AngestelltenKrankenkasse (DAK), Hamburg/Germany; Head
of Product Management and responsible for
developing and contracting all medical and
paramedical services for DAK’s members;
previously, holding positions as a partner at
Roland Berger Strategy Consultants, and as a
product manager for diabetes pharmaceuticals at
Boehringer Mannheim, Mannheim/Germany.
Nick Fahy; Head of unit for health information
within the Health and Consumers DirectorateGeneral of the European Commission. His
university studies were in social, ethical and
political philosophy at the University of Kent at
Canterbury. Agreeing with Marx that whilst
philosophers have interpreted the world, the point
is to change it, he then joined the British civil
service in the Department of Health.
After
working on issues such as European affairs and
pharmaceutical policy he was private secretary to
John Horam MP, junior minister for the National
Health Service, and then to Tessa Jowell MP, the
6
first Minister of State for Public Health. He moved
to the European Commission in 1998, working on
issues including consumer protection, social
protection and social exclusion, and his previous
job until November 2007 was as deputy head of
the health strategy unit, with particular
responsibility for health systems and cross-border
healthcare.
Andras Fehervary, Vice-President, Head of
Market Access and External Affairs for Novartis
Oncology Europe, is responsible for pricing and
reimbursement and access to medicines for
Novartis Oncology medicines in Europe, and for
policy and external affairs communications,
patient advocacy and public affairs, reports to Dr
Guido Guidi, President of Novartis Oncology
Europe; is a member of the Strategy Committee
Oncology Region Europe (SCORE), was Head of
European Policy and Public Affairs and of the
Brussels government affairs office for Eli Lilly &
Company, where he also served as Director
Corporate Affairs AMEA-CIS & CEE regions, as
well as, Director of Payer Planning & Strategy;
former Head of Financial Planning and Strategy Europe with SABMiller Europe, and Senior
Advisor with the venture capital firm iEurope LLC;
received his BA and first graduate degree in
international relations from the Johns Hopkins
University in Baltimore, MD and the Hopkins
School of Advanced International Studies in
Bologna, earned Master's Degrees from the
Graduate Institute of International Studies of the
University of Geneva (IUHEI), and from the
Fletcher School of Law & Diplomacy of Tufts
University, and finally MBA from INSEAD.
Armin H. Fidler, MD, MPH, MSc. Austrian; Lead
Adviser for Health Policy and Strategy, Human
Development Network, The World Bank. From
2000-2008 Sector Manager for Health, Nutrition,
Population for Europe and Central Asia at the
World Bank; MD (University of Innsbruck, Austria);
DTM&H (Bernhard Nocht Institute, Hamburg);
MPH & MSc. (Harvard University’s School of
Public Health); Certificates
in Management
(Harvard Business School) and Public Finance
and Welfare Economics (London School of
Economics and Political Science); Adjunct
Faculty, The George Washington University
School of Public Health and lecturer at the
Management Centre Innsbruck (MCI).
Josep Figueras, MD MP PhD (econ), (1959)
Spanish; Director of the European Observatory on
Health Systems and Policies and Head of the
WHO European Centre on Health Policy (with
research focus on comparative health system and
policy analysis) in Brussels; member of several
advisory and editorial boards and has served as
advisor in more than thirty countries within the
European region and beyond; honorary fellow of
the UK faculty of public health medicine; twice
awarded the EHMA price for the best annual
publication on policy and management; awarded
the Andrija Stampar Medal in 2006; lectured at
and headed the MSc in Health Services
Management at the London School of Hygiene &
Tropical Medicine; editor of the European
Observatory series published by Open University
Press and has published several volumes in the
field of health systems analysis including: Health
systems, health and wealth (2009), Impact of EU
mobility (2009), Health Impact Assessment
(2007), Purchasing to improve performance
(2005), Health Systems in Transition (2004)
Social health insurance (2004) Funding health
care (2002) Critical challenges for European
reform (1998) and European Health Care Reform:
analysis of strategies (1997).
Georg Fischer; is currently Head of Unit for
Social Protection and Social Services in the
Directorate General for Employment and Social
Affairs at the European Commission. His
responsibilities include the assessment of pension
adequacy and sustainability, the Open Method of
Coordination on pensions and health and longterm care and the interaction between EU policies
and social services. From 1996 to 2003 he was in
charge of the work on Employment in Analysis
within the same Directorate General including the
annual "Employment in Europe report", the
economic analysis of European labour markets,
the assessment of the employment impact of
community polices. He was involved in developing
the European Employment Strategy. Prior to this
he worked for the Organisation of Economic Cooperation and Development on employment and
social policies in transition economies, for the
Austrian Government in the Ministries of Finance
and Labour as well as in the Social Science
Centre Berlin and for the Economic Cooperation
Foundation in Tel Aviv, Israel. He is an economist
and studied at the University of Vienna in Austria
as well as the University of Warwick in the United
Kingdom.
Barbon Galuppi, (1962) Italian; practising
accountant, retailer; present position: president of
the Italian Federation of Rare Diseases; high
school diploma in administration and accounting;
president of the Venice City Council for Health
7
Protection; conception and realisation of projects
for the Italian Welfare Ministry.
Juan Garay, Health Team Coordinator, Unit B3:
Human
and
Social
Development,
DG
Development, European Commission.
Pascal Garel, Chief Executive, European Hospital
and Healthcare Federation (HOPE).
Elvira Göbel, Policy Assistant, SANCO C2,
European Commission.
Scott L. Greer, PhD (1976), United States;
Assistant Professor of Health Management and
Policy at the University of Michigan School of
Public Health, and Senior Research Fellow at LSE
Health. His most recent books include “The
Politics of European Union Health Policies” (2009)
and “Devolution and Social Citizenship in the
United Kingdom” (2009).
Tim Harford; is a renowned behavioural
economist, author and award-winning Financial
Times columnist. His two books, The Undercover
Economist and The Logic of Life, have been
translated into 30 languages and sold nearly a
million copies. Tim’s latest work considers what
governments should do when markets fail, and
how economics can be applied to new
technologies, climate change and the challenge of
rebuilding war-torn states; but whilst being a
‘serious’ economist with a career spanning
Oxford, Shell and the World Bank, Tim’s FT
columns dwell on the economics of daily life and
offer tongue-in-cheek solutions to readers’
problems. He also explores consumer behaviour
when times are hard, contrasting detailed
research with tabloid headlines. He shows there
are ‘good’ and ‘bad’ recessions and reveals that
whilst we cut back, we often do so in unexpected
ways. In an alternative presentation, Tim reveals
the hidden logic of the world around us and shows
that human behaviour is actually surprisingly
logical.
Sarah Harvey, Prof., Director of Loop2, Professor
of Public Health, City University London, United
Kingdom.
Wilfried Haslauer, Dr. (1956), Austrian; Deputy
Governor of Salzburg; 1966-1974 Akademisches
Gymnasium in Salzburg, subsequently he studied
law and economics in Salzburg and Vienna and
finished his law doctorate in 1979; after his
obligatory year at the court he consequently
adopted his career as lawyer; 1985-2004
independent lawyer in a chambers in Salzburg,
which he shared with four partners; curator of the
“Seebrunner Kreis”, the think tank of the Austrian
People’s Party and president of the Dr.-WilfriedHaslauer-Bibliothek, a research institute for
political and historical studies; elected deputy
governor since April 2004, re-elected in April
2009; within the new provincial government he is
responsible for the following resorts: economy,
tourism, traffic, construction, museums, special
cultural projects, business-related research and
communities.
Lars Hoelgaard, Deputy Director, DG Agriculture,
European Commission.
Maria M. Hofmarcher-Holzhacker, (1958),
Austrian; Economist, oversees and conducts
applied scientific research in the area of health
and social care in OECD and in transition
countries. She was senior researcher at the
Institute for Advanced Studies (IHS) until October
2009. From November 2009 she is appointed a
staff position at the Austrian Health Institute
(Gesundheit Österreich GmbH). She is the
principal author of Health System Reviews:
Austria and she acts as the Austrian
correspondent of the international health policy
monitor network led by the Bertelsmann
Foundation.
Christoph Hörhan, Mag. (1976), Austrian; since
2006 Director of Fonds Gesundes Österreich,
Gesundheit Österreich GmbH, Vienna; studied
economics at the University of Economics and law
at the University of Vienna (not finished); 19971999 Spokesman of the Official Representation of
Austrian University Students; 2000 Publico PR
and Lobbying, Consulting; 2003 Association of
Industrials, Department of Economics; 2003-2006
Federal Ministry for Health and Women,
Ministerial Office, Head of Communications,
health promotion and prevention; public health
lecturer at different universities (Medical
University Graz, Johannes Kepler University Linz
and MCI Innsbruck); Chair, International Network
of Health Promotion Foundations (INHPF),
Member „Global Scientific Committee“ IUHPE
World Conference 2010.
Mei-Ling Hsiao, Deputy Minister of Health,
Taiwan.
Annie Hubert; European Director Government
and Public Affairs, Amgen. She joined Amgen in
8
2001 where she was till recently the corporate
affairs
director
for
the
Amgen
Belgium/Luxembourg
affiliate.
She
often
represented Amgen at industry associations and
external meetings and is an active member of
different industry working groups dealing with
access, innovation, biotechnology and biosimilars.
She holds a Master in Pharmacy from the
Université catholique de Louvain in Belgium and
obtained the qualification of Industrial Pharmacist
in 1983. She has more than 25 years industry
experience mostly in regulatory affairs, pricing,
reimbursement, government and public affairs
activities.
Michael Hübel, Head of Unit, DG SANCO,
European Commission.
Aagje Ieven, EuroHealthNet.
Carol Jagger, Prof. (1951), British; Epidemiology,
Demography; Professor of Epidemiology and
Director of the Leicester Nuffield Research Unit at
the University of Leicester; Senior Research
Fellow at Newcastle University; BSc Mathematics,
MSc and PhD Statistics; Deputy lead of the EC
Task Force for Health Expectancy, member of
Steering Group of the International Network on
Health Expectancy and the Disability Process
(REVES), Fellow of the Faculty of Public Health,
Fellow of the Gerontological Society of America,
Associate Editor of Age and Ageing. Coinvestigator of the European Health Expectancy
Monitoring Unit (EHEMU) and the European
Health and Life Expectancy Information System
(EHLEIS) both funded by the EC Public Health
Programme.
Patrick Jeurissen, Coordinator Strategy and
Knowledge Management Group, Affairs and
Labour Market Policy Department, Ministry of
Health, Welfare and Sport, The Netherlands.
Panos Kanavos, Prof. Dr.; Senior Lecturer in
International Health Policy in the Department of
Social Policy and Merck Fellow in Pharmaceutical
Economics at LSE Health, UK. He was previously
Harkness Fellow in Health Care Policy at Harvard
Medical School. He has acted as an advisor to a
number of international governmental and nongovernmental organizations, including the World
Bank, the World Health Organization, the
Organization for Economic Co-operation and
Development, the American Association for
Retired Persons, and Ministries of Health of over
21 transition and developing countries. He has
participated in the European Pharmaceutical
Forum, as advisor to the European Commission.
His research interests include comparative health
policy and healthcare reform, pharmaceutical
economics and policy, access to medicines in
developing and transition countries, quality in
healthcare, and socio-economic determinants of
health.
Ursula Karl-Trummer, (1967) Austrian; studied
Sociology and Political Science and Philosophy of
Science at the Universities of Graz and Vienna.
She holds a Masters in Socioeconomic Sciences,
a PhD in Sociology of Medicine, and a MSc for
Organisational Development and Counselling.
Since 1996 Ursula Karl-Trummer is engaged in
practice-oriented research commissioned by the
European Commission, DG Sanco, the Austrian
Government (Ministry of Health, Ministry of
Research), and the private sector; 1993-1996
Junior Scientist at the Institute for Applied
Sociology, Vienna and 1995-96 at the University
of Erlangen-Nürnberg, Department for Sociology
and Social Anthropology; from 1998 to 2008
Researcher at the Ludwig Boltzmann Institute for
Sociology of Health and Medicine (LBISHM),
WHO-Cooperation
Center
(www.univie.ac.at/lbimgs), from 2000 as Senior
Scientist and member of the steering board;
lecturer at various Universities (Vienna, Graz,
Linz, Krems, Marburg), Independent Expert to the
European Commission, DG Sanco and DG
Research, Consultant for the German Ministry for
Education and Science; since 2008 Head of the
Center for Health and Migration, Danube
University Krems, since 1996 General Manager of
the Trummer&Novak-Zezula OEG, a SME
specialised on multidisciplinary research and
development in the field of health care
organisations and health care education aiming at
organisational development; project director of the
Project “Health Care in Nowhereland. Improving
Services for Undocumented Migrants in the EU
(www.nowhereland.info), a project funded by DG
Sanco; main fields of research in health and
migration, health promotion, workplace health
promotion,
transdisciplinary
research
methodology, and organisational development.
Norbert Klusen, Prof. Dr. (1947), German;
Sociology, Psychology and Political Sciences,
graduated in Business Management (DiplomKaufmann), PhD in Economics (Dr. rer. oec.);
President and Chief Executive Officer at
Techniker Krankenkasse (TK), a leading German
health insurance company and a non-profitorganization; Professor of International Health
Care Policy and Systems at Leibniz University
9
Hannover, Professor of Health Care Economics
and Health Care Policy at the University of
Applied Sciences of Western Saxony, Visiting
Professor of Health Management and Health
Policy at University of Michigan, Ann Arbor
(2009).
Cécile Knai, Dr. (1972), French; Lecturer, PhD
Public Health and Policy at the London School of
Hygiene & Tropical Medicine; currently involved in
two EU-funded projects, 1) on assessing the
policy response to obesity and measuring
‘obesogenic’ environments in Europe (EUROPREVOB) and 2) on the evaluation of chronic
disease management programmes in Europe
(DISMEVAL).
Berthold Viktor Koletzko, Prof., Dr von Hauner
Children’s Hospital, University of Munich.
Monika Kosinska, (1978), British/Polish; Public
Health Policy and Advocacy, European and
International Law: Secretary General of the
European Public Health Alliance, membership
organisation representing approximately 100 nonprofit organisations working in health; Board
member of the Health and Environment Alliance,
the Civil Society Contact Group and former Chair
of Action for Global Health; Member of the EU
Health Policy Forum, the EU Platform against
Obesity and the EU Alcohol Forum; Co-founder of
the EUREGHA network bringing 450 regions
across Europe together to work on health issues.
Sophie Koutouzov, Dr., has obtained her PhD in
1982 and was appointed as a full-time scientist at
the French National Institute for Scientific and
Medical Research (INSERM) in 1986. She was
trained as a pharmacologist and shifted to
immunology, in the early 90s. Since then, her
studies focused primarily on autoimmune
disorders, in particular in the etiopathological
mechanisms of systemic lupus. After a sabbatical
year at Baylor Institute for Immunology Research
in Dallas (USA) in 2001 followed by a two-year
appointment as Associate Investigator in the
same Institute, she moved back to Paris to
continue her work on the role of Interferon alpha
in lupus etiology. Her long interest in lupus
(classified as a rare disease) along with her will to
shift from basic science to research organization
and coordination made her move to the GisInstitute for Rare Diseases in which she was
appointed as General Secretary in 2007. She is
currently the coordinator of the European
Commission 6th FP-funded E-Rare project on
coordination of research in rare diseases.
Pieter Kramers, Dr. (1944), The Netherlands;
biology, genetics, toxicology, epidemiology, public
health; currently active as free-lance advisor for
the Centre for Public Health Forecasting, National
Institute of Public Health and the Environment
(RIVM), Bilthoven, The Netherlands; former head
of this Centre; co-editor of Dutch national public
health reports 1993-2006; involved in DGSANCO-funded projects on health indicators
(coordinator of ECHI 1998-2005, participant in
ECHIM 2005-2011) and other projects and
working parties under the information strand
(EUPHIX, ISARE, etc); member of Dutch and
European public health societies.
Finn Boerlum Kristensen, M.D., Ph.D.;
Chairman of the Executive Committee, European
Network for Health Technology Assessment,
EUnetHTA, and Director of the Coordinating
Secretariat, National Board of Health, Denmark.
Adjunct professor in health services research and
health technology assessment at University of
Southern Denmark from 1999; 1997-2009 Director
of Danish Centre for Health Technology
Assessment (DACEHTA), National Board of
Health, Denmark; University graduate in medicine,
PhD in Epidemiology, Specialty in General
Practice. Specialty in Public Health; International
projects in the areas of health services research,
epidemiology, health technology assessment, and
clinical practice guidelines since 1980ies;
Chairman International Network of Agencies for
Health Technology Assessment (INAHTA) 2003 06, Project Leader of EUnetHTA, 2006-08
(www.eunethta.net); Editor of Health Technology
Assessment Handbook (English, translated from
Danish) 2007 and chief editor of three peer
reviewed publication series from DACEHTA, 1998
– 2009; Member, UK NHS HTA Programme
Advisory Group since 2005; Chair, Scientific
Council, Ludwig Boltzmann Institute of Health
Technology Assessment, Austria since 2007.
Ken N. Kuo, MD Prof. (1940) Taiwan; Health
policy researcher and pediatric orthopedic
surgeon. He is currently the Director and Principal
Investigator at Center for Health Policy Research
and Development, National Health Research
Institutes in Taiwan, which is an important think
tank for health policy for the government.
Professor Kuo received his medical degree from
College of Medicine, National Taiwan University.
He had postgraduate training in orthopedic
surgery at University of Illinois Medical Center in
Chicago. He further received fellowship in the
Hospital for Sick Children in London and
10
University of Edinburg in Scotland. He was the
professor of Orthopedic Surgery and Residency
Program Director at Rush University Medical
Center in Chicago. In the field of health policy
research, he had conducted many projects in the
past, including physician manpower study in
Taiwan, physician manpower projection, Taiwan
Tobacco Control Forum, Institutional Review
Board Accreditation in Taiwan, development of
evidence based medicine and clinical practice
guidelines as well as education and promotion, elearning development. He serves at advisory
capacity to Department of Health in Taiwan in
graduate medical education, health promotion
funds, and international health corporation. He
was also a major organizer in many international
health policy conferences. Most recent work is
conduct the forum for Healthy People 2020 in
Taiwan and published white paper.
Taavi Lai, Senior Analyst, Department of Health
Information and Analysis, Ministry of Social
Affairs, Estonia.
Wolfram Lamping, PD Dr. (1965), German;
Political Scientist, Associated Professor at the
University of Hannover, Institute for Political
Science, currently Substitute Professor at the
University of Bremen, Center for Social Policy
Research.
Günther Leiner, MD (1939) Austrian, doctor of
internal medicine, is the President of the
International Forum Gastein and the founder of
the European Health Forum Gastein; former
medical director of the “Badehospiz”, Bad
Gastein. He was re-elected as member of the
Austrian Parliament in 1999, where he was
Deputy Chair of the Health Committee and
fraction leader of his party. As MP he was the
representative of the Austrian Parliament in the
Roundtable on Human Genetics of the European
Parliament. In the early 1990s he founded the
International Forum Gastein. Günther Leiner was
also the President of the “Salzburger Hilfswerk”
which he established in the late 1980s. The not for
profit organisation with some 800 employees
delivers home health services, domestic aid,
support to the elderly and related services.
Fredrik Lennartsson, (1966), Swedish; DeputyDirector General and Head of Department for EU
and International Affairs at the Swedish Ministry of
Health and Social Affairs (2005-, Responsible for
Swedish EU-Presidency in the areas of Health
and Social Policy, Economist (M.Sc.), Swedish
Government Representative on the EU High Level
Group on Health Services and Medical Care, the
Council Health Working Party at Senior Level,
High Level Group on Demographics, the
European Observatory on Health Care Systems
Steering
Committee
(2003-2007),
the
WHO/EURO Regional Search Group (20082009). Previously (2002-2005) Health Policy
Advisor at the Ministry of Health.
Colin Mackay, Director
Partnerships, EFPIA.
Communications
&
Robert Madelin, (1957); since 2004 DirectorGeneral for Health and Consumers; he has overall
responsibility for the day-to-day running of the
work of the Directorate-General in its three main
areas: public health, food safety and consumer
protection. Robert was educated in England at the
Royal Grammar School, High Wycombe and at
Magdalen College, Oxford. He has also studied at
the Ecole Nationale d’Administration in Paris. He
has previously served as a Director in the
Directorate-General for Trade, and was Deputy
Head of Cabinet to Sir Leon (now Lord) Brittan,
European Commission Vice-President.
Guðjón Magnússon, Dr. (1944), Iceland;
Professor of Public Health and director of MPH
programs at Reykjavík University; MD from
University of Iceland and a specialist training in
Public Health in Edinburgh, Scotland and
Stockholm, Sweden, PhD from Karolinska
Institute, Stockholm; Deputy Chief, Medical Officer
and Deputy Permanent Secretary for the Ministry
of Health and Social Insurance Iceland. Dean of
the Nordic School of Public Health,
Director of Health Programs, WHO Regional
Office for Europe, Copenhagen. Past President of
Icelandic Red Cross and Vice president of the
International Federation of Red Cross and Red
Crescent Societies.
Fredmund Malik, Prof. Dr., Austrian; one of the
most renowned general management experts in
the German speaking countries and beyond. He
has been a professor of general corporate
management for more than 30 years at the
University of St. Gallen, Switzerland, for Business
Administration, Economics and Law; awarded
author of more than 10 books on Hholistic
General Management and Leadership and of
hundreds of articles; he is also a successful
entrepreneur, having built the world’s largest
extra-universitary research, consulting and
implementation organisation on holistic general
management, employing 300 people, with offices
11
in St. Gallen, Zürich, Vienna, Berlin, Shanghai,
London, and Toronto. www.malik-mzsg.ch
Michael G. Marmot, Professor Sir, PhD (1945);
Director, International Institute for Society and
Health, MRC Research Professor of Epidemiology
and Public Health, University College London.
Michael Marmot has led a research group on
health inequalities for the past 30 years. He is
Principal Investigator of the Whitehall Studies of
British civil servants, investigating explanations for
the striking inverse social gradient in morbidity
and mortality. He leads the English Longitudinal
Study of Ageing (ELSA) and is engaged in several
international research efforts on the social
determinants of health. He chairs the Department
of Health Scientific Reference Group on tackling
health inequalities. He was a member of the Royal
Commission on Environmental Pollution for six
years and is an honorary fellow of the British
Academy. In 2000 he was knighted by Her
Majesty The Queen for services to Epidemiology
and
understanding
health
inequalities.
Internationally acclaimed, Professor Marmot is a
Vice President of the Academia Europea, a
Foreign Associate Member of the Institute of
Medicine (IOM), and was Chair of the
Commission on Social Determinants of Health set
up by the World Health Organization in 2005. He
won the Balzan Prize for Epidemiology in 2004,
gave the Harveian Oration in 2006 and won the
William B. Graham Prize for Health Services
Research in 2008. He is currently conducting a
review of health inequalities at the request of the
British Government.
Patricio Marquez, World Bank Lead Health
Specialist.
Kevin McCarthy; Head of Sector Public Health in
the Medical and Public Health Research unit, in
the Directorate-General for Research of the
European Commission. Mr. McCarthy has
responsibility for a small team implementing the
area: "Optimising the delivery of health care to
European citizens" as well as international public
health and health systems, under the Health
Theme of the Cooperation Programme of the 7th
Framework Programme for Research (20082013). He also oversees as the health related
scientific support to policies activities under the
6th Framework Programme.
David McDaid, Dr., Senior Researcher, LSE
Health & Social Care.
Martin McKee, CBE (British/Irish) is Professor of
European Public Health at LSHTM, London
School of Hygiene and Tropical Medicine, codirector of the European Centre on Health of
Societies in Transition (ECOHOST), a WHO
Collaborating Centre, and research director in the
European Observatory on Health Systems and
Policies. He has written extensively on health and
health policy in Europe. His work has been
recognised by, among others, the 2003 Andrija
Stampar medal, honorary doctorates from
Hungary and The Netherlands, Fellowship of the
UK Academy of Medical Sciences, and
membership of the US Institute of Medicine.
Laurie McMahon, Prof., Director, Loop2,
Professor of Health Policy, Cass Business School
London, United Kingdom.
J. Gordon McVie, Prof. (1945), Scottish; Head of
Clinical Research Coordination, Strategy and
International Affairs and Director of Cancer
Intelligence at the European Institute of Oncology
(IEO). He served as Chief Executive of the UK’s
Cancer Research Campaign (CRC); Clinical
Research Director at the National Cancer Institute
of the Netherlands; President of EORTC
(European Organisation for Research and
Treatment of Cancer) and Board Member of UICC
(International Union Against Cancer). He is the
recipient of numerous awards including Fellow of
the Royal College of Surgeons of Edinburgh. He
has authored over 300 peer-reviewed articles and
contributed to over 35 books.
Melinda Medgyaszai, Dr. (1963), Hungarian;
Medical Micro-biology, Social Medicine, Health
Insurance; Secretary of State; responsible for
Health Policy in Ministry of Health of Republic of
Hungary; Board member of EUMASS and
Hungarian Life Insurance Society (MÉBOT).
Nata Menabde, Dr. (1960) Georgian; Deputy
Regional Director of the WHO Regional Office for
Europe; Dr. Menabde has a solid public health
academic background (MSc in pharmacy, PhD in
pharmacology) and 25 years of experience as a
health professional, during which she has built an
extensive track record in public health and health
systems at country and international levels. As a
leader, she has proven her ability to instil a clear
vision, effective teamwork and high performance
in the organizations she has led. As the current
Deputy Regional Director, she has a unique
knowledge of WHO Europe, where she has
tenaciously promoted strategic and results-based
partnerships with other institutions. Dr Menabde is
12
a dedicated member of WHO’s global team and
she has effectively supported implementation of
changes introduced by the WHO Director-General
in
the
Organization.
Professionally,
her
accomplishments extend from the Georgian
Ministry of Health to WHO, from spearheading
effective humanitarian operations and modern
pharmaceutical regulation in Georgia to greater
efficiency of WHO Country Offices and upgraded
institutional service to WHO’s Member States.
Since she took on her current position in 2006, Dr
Menabde has vigorously promoted the primary
care-based health systems agenda, culminating in
adoption of the Tallinn Charter in June 2008. Her
extensive public health agenda track record
includes accomplishments in the areas of
tuberculosis and HIV/AIDS, noncommunicable
diseases and risk factors such as tobacco and
obesity, climate change and other environmental
concerns, the International Health Regulations
and other aspects of health security, intellectual
property rights and the social determinants of
health. She has effectively chaired the Emergency
Steering Committee. She also has successfully
partnered with key stakeholders such as the
Council of Europe, the European Union, the
European Commission, UNICEF, the World Bank,
OECD, the Global Fund, the European Investment
Bank and others to increase the effectiveness of
WHO’s work.
Piotr Mierzewski, (1950), Polish; physician, a
specialist in public health and paediatrics (Medical
University, Gdansk, Poland); Head of the Health
Division, Directorate General III – Social
Cohesion, Council of Europe, Strasbourg, France.
He is also the secretary of the European Health
Committee (CDSP). He was a founding member
of the Solidarity ("Solidarnosc") movement (19801981). He served as the First Deputy Minister of
Health in the first non-communist government in
Poland (1989-1992), then as the director of the
National Centre for Health System Management,
Warsaw.
Ana Mitrovic,
MD PhD; Specialist in
Gynaecology and Obstetrics, Head of infertility
department of the University hospital, President of
Society of reproductive health, Associated
professor University of Belgrade School of
Medicine.
Wilhelm Molterer, Mag. (1955), Austrian; former
Vice-Chancellor and Federal Minister; 1974-1980
studies (social economics) at Johannes-KeplerUniversity
Linz,
1980
Graduation
to
Mag.rer.soc.oec.; professional career (selection):
1989-1993 Director of the Austrian FarmersFederation, 1993-1994 Secretary General of the
Austrian People’s Party, 2003-2006 Chairman of
the Austrian People’s Party Parliamentary Club,
1993-1998 Board Member of the Austrian
People’s Party, 1995-2007 deputy Chairman of
the Austrian People’s Party; 1994-2000 Federal
Minister of Agriculture and Forestry, 2000-2003
Federal Minister of Agriculture, Forestry,
Environment and Water Management, 2007-2008
Vice-Chancellor, 2007-2008 Federal Minister of
Finance.
Frank Ulrich Montgomery, Dr. (1952), German;
he graduated from Hamburg University in 1979
after medical studies in Hamburg and Sydney and
is currently working as a consultant in Radiology
at the University Hospital in Hamburg; Vice
President of the Standing Committee of European
Doctors (CPME) for 2008-2009, and was reelected for the period 2010-2011. 1989–2007 he
chaired the "Marburger Bund" (www.marburgerbund.de), the professional organisation of the
hospital-based, employed physicians of Germany
with more than 100.000 members. Under his
leadership
this
organisation
has
made
tremendous progress in representing hospital
doctors. He is very much engaged in working-time
matters and in negotiating wages and salaries.
Montgomery was also on the board of the
Bundesärztekammer for almost sixteen years.
From 1994 until 2002 he was elected President of
the Hamburger Ärztekammer, an office which he
regained in 2006. In 2007 he was elected VicePresident of the Bundesärztekammer. His main
political interests are health-care financing and
structural questions of the organisations of healthcare. He is also very engaged in all ethical
matters related to the medical profession.
Antoni Montserrat, Catalan; Policy Officer for
Rare Diseases, Neurodegenerative diseases and
Health Surveys in the Unit Health Information of
the Directorate of Public Health of the European
Commission
(Luxembourg).
Professional
background: Eurostat (Health statistics, social
statistics); academic background: Economy and
statistics, Computational Linguistic.
Luis A. Moreno, Prof. (1958), Spanish; Medicine,
Professor of Public Health at the University of
Zaragoza (Spain); Human Nutrition and Public
Health at the University of Nancy (France);
several grants from the Spanish Ministry of Health
and the EU 6th and 7th Framework Programmes
(HELENA, IDEFICS, EURRECA, ENERGY,
ToyBox projects); author of more than 120 papers
13
published in peer-reviewed journals; coordinator
of the E.U. project HELENA (Healthy lifestyle by
nutrition in adolescence); member of the
ESPGHAN (European Society of Paediatric
Gastroenterology, Hepathology and Nutrition)
Committee of Nutrition; Associate Editor of “BMC
Public Health” and “Nutrition, Metabolism and
Cardiovascular Diseases”.
Elias Mossialos, Prof.; Department of Social
Policy, London School of Economics.
Trevor Mundel, Dr. (1960), Dutch/South African;
Global Head of Pharma Development for Novartis
based in Basel, Switzerland; Medical Degree Johannesburg, South Africa; Rhodes Scholar,
Mathematics, Logic and Philosophy, Oxford
University; Graduate studies in Mathematics,
University of Chicago; Neurology Residency in
University of Chicago Hospital.
Elisabeth
Muschik,
(1943)
Austrian;
Psychotherapist; Mental Health Europe – Member
of Accreditation & Membership Committee, „MHE
– National Focal Point“ in Austria; Board Member
of Pro Mente Austria (responsible for national and
international lobbying), Board Member of Pro
Mente Wien; 2006-2009 Vice President of MHE,
until 2009 Vice President of Pro Mente Austria,
Member of EAP (European Association of
Psychotherapy); private active until 2004, HansStrotzka-Award for Social Psychiatry in Austria
2008.
Clive Needle; Director of EuroHealthNet, the
Brussels –based organisation networking public
health bodies in EU states. Originating from the
EU network of health promotion agencies,
EuroHealthNet has prioritised promoting health
equity and tackling health inequalities across all
EU policies. Its work is accessible via its family of
websites: www.eurohealthnet.eu; www.healthinequalities.eu;
www.equitychannel.net
and
www.healthgradient.eu or via its team based at
Rue de la Loi 67 in central Brussels. Clive is also
an independent advisor, lecturer, facilitator and
writer on international public policy issues.
Katja Neubauer, (1966) German; Biologist,
Health Strategy and Health Systems Unit of
Directorate-General Health and Consumers,
European Commission; responsible for the Green
Paper on the EU Workforce for Health and for the
Council Recommendation on Patient Safety.
Hanna Nohynek; Senior Scientist, Vaccines and
Immune Protection, National Institute for Health
and Welfare, Finland.
Ellen Nolte, MPH, PhD; Director Health &
Healthcare, RAND Europe, and Honorary Senior
Research Fellow at the European Observatory on
Health Systems and Policies. Her main research
is the field of health systems including approaches
to health system performance assessment, health
system responses to chronic disease, international
health care system comparisons, and trends and
determinants of population health in former
communist countries of central and eastern
Europe. She is a member of International
Scientific Committee of the European Public
Health Association (EUPHA).
Hans-Dieter Nolting, (1960), German; Member of
the Board of the IGES Institute GmbH in Berlin
Germany, heads the divisions Consulting Health
Insurances, Work & Health and leads the
researches in the field of Consumer Preferences
in Health Care. After studying Psychology and
Philosophy in Berlin and Bordeaux, Hans-Dieter
Nolting worked as a research associate at the
Institute of Social Medicine and Epidemiology at
the Federal Health Office (nowadays "RobertKoch-Institute"). Since 1991 he has been working
for the IGES Institute. He directed research and
consultancy projects in the fields of preventive
and occupational health, quality management in
health care, evaluation of health care programmes
and
business
development
of
health
insurances.Today, he focuses on systematic
issues of health care systems and advice of
health insurances in matters of benefit
management, contract management, financing
issues, marketing and distribution.
Christel Nourissier; Secretary General of
EURORDIS, the European Organisation for Rare
Diseases, which brings together numerous patient
associations in 37 countries. Christel Nourissier is
the mother of a 33 years old young woman born
with a rare disease, Prader-Willi syndrome, who
was diagnosed when she was 16 years old. Since
then, she has been relentlessly fighting for
diagnosis and access to care for people living with
rare diseases across Europe. She coordinated
two European conferences, to raise awareness
about rare diseases, in 2003 and 2005 and
worked for several European projects and
research networks. She participated in the first
National Plan for Rare Diseases in France (20052008) and today she represents EURORDIS at
the Rare Diseases Task Force of the European
14
Commission. She was involved in the
Communication of the Commission and the
Recommendations of the Council for Rare
Diseases adopted in June 2009 and is an advisor
in the EUROPLAN project. She is also vice-chair
of a Committee for Rights and Autonomy of
people with disabilities in France.
Laura Otero Garcia, National Center of Tropical
Medicine, Instituto de Salud Carlos III, Ministerio
de Ciencia e Innovacion.
Willy Palm, Dissemination Development Officer,
European Observatory on Health Systems and
Policies.
Antonyia Parvanova, Dr. (1962), Bulgarian;
Paediatrician and Public Health policy expert,
is currently Member of the European Parliament,
Vice-President of the Alliance of the Liberals and
Democrats for Europe, and seats as a full
Member of the Committee on the Environment,
Public Health and Food Safety. Following her
career as a clinician and researcher in Bulgaria
and in the UK, Dr. Parvanova started her political
career when elected Member of the Bulgarian
Parliament in 2001. In the European Parliament
she initiated several public health policy actions,
notably the campaign on patients' rights in
Europe.
Mieczyslaw Pasowicz, Dr.; CEO, The John Paul
II Hospital.
Morten Frank Pedersen; Head of Novo Nordisk’s
Brussels office. He joined Novo Nordisk’s
Brussels in June 2009. Prior he worked at
GlaxoSmithKline Pharma’s Denmark office first as
a public affairs director and then as a corporate
affairs director and transferred to the Brussels
office in 2007. He holds a master in political
science from the Århus University of Denmark and
is a member of Danish Top Executive Network
and of industry committees inside EFPIA.
Carmen Perez-Rodrigo, MD; Specialist in
Preventive Medicine and Public Health, special
postgraduate training in the field of Nutrition and
Public Health, nutrition, education and community
health. Currently Coordinator of the Community
Nutrition Unit at Bilbao Department of Public
Health (Spain); she has coordinated population
nutrition surveys at the local, regional and national
level and has been involved in the design,
implementation and evaluation of intervention and
nutrition education programmes, particularly in the
school setting. Coordinator of the PERSEO
Project (2006-2009), promotion of healthy eating
and physical activity in Primary Schools. She has
been or is currently involved in European projects,
such as EURRECA, Eurobese, Pro Children
(Promoting and sustaining health through
increased vegetable and fruit consumption among
European schoolchildren) or Eurodiet. Editor of
Revista Española de Nutrición Comunitaria;
member of the Editorial board of Public Health
Nutrition and Health Education. Member of the
Council of the Spanish Society of Community
Nutrition; member of the Executive Committee of
the International Society for Behavioral Nutrition
and Physical Activity (ISBNPA); member of the
Council of the European Academy of Nutritional
Sciences (EANS). Founding member of the World
Public Health Nutrition Association (WPHNA).
Galina Perfilieva, Dr.; Regional Adviser, Health
Sector Human Resources, World Health
Organization Regional Office for Europe.
Govin Permanand, Dr., Programme Manager,
Health Evidence Network, WHO Regional Office
for Europe.
Bosse Pettersson; Senior Public Health Policy
Adviser, with longstanding Swedish and
international experience in health promotion and
disease prevention since 1976. He was former
Deputy Director-General of the Swedish National
Institute of Public Health and since 2009 a Senior
Adviser in Global Health Policy to the Swedish
Ministry of Health and Social Affairs. Bosse
Pettersson is also a contract Senior Lecturer at
the Karolinska Institute and is regularly contracted
by WHO, EU and other organisations in Europe.
He was also the chair of the WHO/Euro task force
preparing the European strategy for the
prevention and control of non communicable
diseases 2004-06.
Rosa Ramirez, Deputy Director General, Ministry
for Health and Consumer Affairs, Spain.
Bernd Rechel, Dr. (1970), German; Researcher
at the European Observatory on Health Systems
and Policies and Honorary Lecturer at the London
School of Hygiene & Tropical Medicine; working
on health systems and policies in Eastern Europe
and Central Asia, capital investment in Europe,
and migration and health.
Ana Raquel Reis Nunes, Young Gasteiner.
Ulrik Ringborg, Prof. (1941), Swedish; PhD
thesis in basic biology; Director of the Cancer
Centre in the Karolinska Institute, Stockholm,
15
Sweden; Member of the Board and Policy
Committee of the European CanCer Organisation
(ECCO); Member of the Research Board and the
Governing Body of the Stockholm Cancer Society;
Member of the Research Board and the
Governing Body of the King Gustaf V Jubilee
Fund; Member of the Research Board and the
Governing Body (Vice Chairman) of the Swedish
Cancer Society. Awards for his work include
Honorary Membership of the Radiological Society
of North America and the Hungarian Cancer
Society. Author of approx. 280 international
publications, his scientific focus is on malignant
melanoma.
Tamsin Rose, Independent EU Health Advocate,
Brussels, Belgium.
Magdalene Rosenmöller, Senior Lecturer, IESE
Business School, Barcelona.
Maja Rupnik Potokar, (1973) Slovenian; she
holds a degree in political science (international
relations) from the University of Ljubljana. She is a
project and policy officer in the Health Information
Unit of the Directorate-General for Health and
Consumers in the European Commission. She
works mainly on European policy and action on
cancer. Previously in her career she was a Health
Counsellor at the Permanent Representation of
the Republic of Slovenia to the EU and she was
also centrally involved in planning and delivery of
the Slovenian Presidency of the Council of the EU
in the area of health. Before that she worked in
the EU Affairs and International Cooperation
Service at the Slovenian Ministry of Health.
Giancarlo Ruscitti, MD; Director General for
Social & Health Care Planning of the Veneto
Region,
Italy;
Vice-President
of
FITOT
(Foundation for the Increase in Organ
Transplants, Padova) and of the Foundation of the
Eye Bank of Venice; Member of the Board of
Directors of the European Observatory on Health
Systems and Policies; he is a representative for
the Veneto Region in the G6 high level Working
Group on behalf of the Health Commission of the
Italian Regions, is coordinator of the Regional
Coordinating Unit for Food Safety and currently
presides the Regional Committee for Health
System Emergencies (C.R.E.S.S.); previously he
was Director of Business Development Health
Care for Italy & Southern Europe on behalf of
ORACLE EMEA; from 1995 to 2001 he was
Director of Informatics and Organization Systems
of "Bambino Gesù" Pediatric Hospital in Rome.
He is a professor of Medical Information
Technology and Health Care Organization for the
Regional Institute of Training & Education (IREF)
of the Lombardy Region, and holds a part-time
post as Professor of Medical Information
Technology at the Faculty of Medicine, University
of Brescia. From 1995 to 1998 he was the Italian
Coordinator of the G7 Global Healthcare Activities
and Italian representative at the XIII Directorate
General of the European Commission for Health
Telematics Programmes & TIDE. From 1987 to
1995 he worked at the "Tor Vergata" University of
Rome in the Department of Internal Medicine,
then in the Department of Experimental Medicine.
Mandy Ryan, Prof.; joined the Health Economics
Research Unit (HERU) at the University of
Aberdeen 1987, after graduating from the
University of Leicester in 1986 with a BA (Hons) in
Economics and from the University of York with
an MSc in Health Economics. In 1995 she
graduated from the University of Aberdeen with a
PhD in Economics concerned with the application
of contingent valuation and discrete choice
experiments in health economics. In 1997 Mandy
was awarded a 5-year MRC Senior Fellowship to
develop and apply discrete choice experiments in
health care, in 2002 she was awarded a Personal
Chair in Health Economics by the University of
Aberdeen and in 2006 she was elected as a
Fellow of the Royal Society of Edinburgh.
Professor Ryan currently directs the Preference
Elicitation Theme within the Preference Elicitation
and Assessment of Technologies (PEAT)
programme of work within HERU. She has worked
with
academics,
government
and
the
pharmaceutical industry and has published widely
in the field of health economics generally, and
monetary valuation more specifically. Professor
Ryan also has extensive teaching experience, and
is currently Director of HERU's Distance Learning
Course.
Andrzej Ryś, Director in Directorate C – “Public
Health and Risk Assessment”, in DG "Health and
Consumers", European Commission. Andrzej Ryś
is a medical doctor graduated from Jagiellonian
University, Krakow, Poland. He specialized in
radiology and public health. In 1991 he
established School of Public Health (SPH) at the
Jagiellonian University and he was the SPH's
director till 1997. From 1997-1999 he took up the
post of director of Krakow’s city health
department. In 1995 –1999 he was the Polish
director of the “Harvard-Jagiellonian Consortium
for Health” – a project focusing on local
governments' role in health care. In 1999 – 2002
he became the deputy Minister of Health in
16
Poland and developed a new system of
emergency medicine and new education system
for nurses. He was a member of the Polish
accession negotiators team. In 2003 he
established and ran as a director, the Center for
Innovation
and
Technology
Transfer
at
Jagiellonian University, Krakow, Poland. He was
also director for development of Diagnostic Ltd.,
executive director of the Polish Association of
Private Health Care Employers and chief editor of
the Journal "Health and Management". He joined
the European Commission in June 2006.
Arne-Petter Sanne, (1965), Norwegian; 1992
MBA, Norwegian school of Economics and
Business Administration, Bergen; 2001 MIHMEP
(Master International Health Care Management,
Economics and Policy), Università Bocconi, Milan;
1992-93 Consultant, Red Cross Hospital, Oslo;
1993-96 Logistic Manager, Smith and Nephew;
1996-98 Controller, BENOVA; 1998-99 Finance
Manger, Deutag Offshore; 1998-2005 Manager,
PricewaterhouseCoopers; 2005-present Director,
Head International affairs, Norwegian Directorate
of Health, General Assembly member EDCTP
(European and developing countries clinical trial
partnership), Editor “Health creates welfare” The
Norwegian health system, 2008.
Erika Scharer, (1952), Austrian; Regional
Councillor for Health and Social Affairs in the
Salzburg Regional Government. Apprenticeship
as an office assistant and accountant; joined the
Regional Chamber of Labour and appointed as
head of the office in the Pinzgau district. Member
of the Austrian National Assembly for the Austrian
Socialist Party (SPÖ) 2002-2007. After the cablerailway disaster in Kaprun in 2000, Erika Scharer
directed the crisis intervention centre and
coordinated bereavement care for friends and
relatives of the victims. She also gained much
experience in integration work for Bosnian
refugees and organized aid transport for
Romania.
Robert Schlögel, Dr. (1947), Austrian; Honorary
University Professor, Director General of Division
II (Consumer Health and Health Prevention),
Federal Ministry of Health; Member of the Socialand Health Forum Austria of the Main Association
of Austrian Social Insurance Institutions,
Representative from Austria in the High Level
Group on Health Services and Medical Care of
the EU, Representative In the Board of the
Austrian Academy of Occupational Medicine,
Vice-President of the Austrian Academy of
Preventive Medicine and Health Communication;
Medical Education and doctor-to-be at the
Institute of Physiology in Innsbruck, Assistant
Medical Director at the Department of Surgery
and Plastic Surgery at the University-Hospital in
Innsbruck; 1985-1997 Commander and Medical
Director of the Military Hospital, Innsbruck, 19972002 Surgeon General of the Austrian Army,
since 2000 Professor for Disaster Medicine at the
University lnnsbruck and since 2003 Professor for
Health Science at the University for Health
sciences, medical informatics and technology
(UMIT) Innsbruck; Honorary Member of the
Austrian Medical Society for Pediatrics.
Karl-Jürgen Schmitt, Dr. rer. nat.; Since 1998,
Dr. Schmitt is appointed Vice-President for
European Governmental Affairs for Siemens AG,
Healthcare Sector. In his position, he
internationally fosters the change process of
healthcare systems towards more prevention and
increase of efficiency. The goal is to support
regions, countries and decision makers in
healthcare in ensuring high quality and becoming
more efficient - based on innovative technologies,
process optimization, more transparency and
competition. Being recognized as an expert on a
wide range of healthcare issues including eHealth,
he is speaker at international conferences and a
Member of the Board of the European Health
Forum Gastein (EHFG). Dr. Schmitt started his
career in the Healthcare Industry, when in 1989
he joined the Diagnostic Ultrasound Division of
Siemens AG, Healthcare, in Erlangen/Germany.
He has held increasingly responsible positions
from R&D to marketing and sales, spending two
years as a Senior Product Manager at the
Siemens Healthcare Ultrasound Division in
Issaquah, WA, USA. A German citizen, he
graduated
from
the
Friedrich-AlexanderUniversity, Erlangen (Germany) in 1988 earning
his degree as Doctor of Physics (PhD). From
1988 to 1989 he worked as an academic
counselor at the Institute for Theoretical Physics
at the Friedrich-Alexander University, Erlangen.
Marc Schreiner, Deputy Head of Health Policy
Department, German Hospital Federation - DKG
e.V..
Ulrik Schulze, Danish; leads BCG's (Boston
Consulting Croup) Health Care Practice in
Switzerland and is a senior member of the firm's
global Health Care Practice. He joined BCG's
Boston office in 1997 and transferred to the Zurich
office in 2001. Prior to joining BCG, Ulrik worked
as a postdoctoral fellow at Department of
Chemical Engineering and Department of Biology
17
at the Massachusetts Institute of Technology
(MIT). He holds a MSc in chemical engineering
from the Technical University of Denmark, and
earned a Ph.D. in Biotechnology from the
Technical University of Denmark.
SANCO, EC); Board member of the Central &
Eastern European Genetic Network (CEEGN);
Vice-chair of the National consultative committee
on rare diseases at the Bulgarian Ministry of
health.
Bernhard Schwarz, Univ.Prof. Dr.med. (1961),
Austrian; physician, academic staff member of
Medical University Vienna; Vienna Medical School
1979 to 1984; certified medical specialist in public
health since 1993, certified health psychologist
since 1993, several postgraduate educations;
president of the Austria Society of Health
Economics; president of the Austrian Cancer
Society Lower Austria, board member of Karl
Landsteiner Gesellschaft; Professor at the Center
of Public Health, Medical University Vienna since
1997; head of Karl Landsteiner (former Ludwig
Boltzmann) Institute for health Economics since
2001; head of the Health Center of the Bank
Austria Group since 2002.
Hans Stein, Dr. (1937) Germany; Ministerialrat
a.D.; FFPH; School education in Germany, India
and Egypt. Universities Geneva, Innsbruck and
Munich, degree in Law; Large number of
publications on European health policy issues,
Consultant in “EU Health Policy” for various
European and national institutions such as
European Commission (DG Health and DG
Research), European Observatory on Health
Systems Brussels; European Public Health Centre
Düsseldorf; European Health Forum Gastein;
lecturer in German schools of Public Health in
Düsseldorf, Munich, Magdeburg; Till end of 2002
Department Head in German Ministry for Health
Bonn, responsible for “European Health Policy”;
German representative in large number of Council
and Commission committees on Public Health,
Health Policy, Health Services and Public Health
Research.
Carlos Segovia, Dr. (1954), Spanish; family
physician, Assistant director for International
Research Programmes of the Institute of Health
Carlos III, expert at the Health Programme
Committee of the 7th Framework Programme
(FP7), National Focal Point for the second Health
Programme
(2008
–
2013),
Spanish
representative in IARC, TDR and IANPHI.
Paul H. Smit, Dr. (1949), Dutch; Chemist, Senior
Vice
President,
Strategy
and
Business
Development, Philips Healthcare, Chemistry &
Physics, chair of COCIR’s Sustainable Healthcare
team, member of Dutch Healthcare Innovation
Platform, chair of the ETP NanoMedicine.
Despina Spanou, Deputy Head of Commissioner
Vassiliou's Cabinet, European Comission.
Wolfgang Sperl, Prof. M.D., Ph.D. (1956),
Austrian, Pediatrician; Head of the Department of
Pediatrics,
Paracelsus
Medical
University;
Research Field: Inborn errors of Metabolism,
Mitochondrial diseases; Member of the Society of
Studies of Inborn errors of Metabolism (SSIEM),
APS (Arbeitsgemeinschaft für Pädiatrische
Stoffwechselstörungen).
Rumen Stefanov, Dr. (1972), Bulgarian;
Associate professor in public health; Director of
the Information Centre for Rare Diseases and
Orphan Drugs (ICRDOD) in Bulgaria; Head of the
Department of social medicine and public health,
Medical university of Plovdiv; Member of the
European Task Force on Rare Diseases (DG
Alois Stöger, diplômé (1960); Austrian Minister of
Health; education and training: apprenticeship as
a machinist, final apprenticeship examination in
the trades of toolmaker and lathe operator, 198687 Social Academy of the Chamber of Labour,
Vienna, 1995-96 European Trade Unions
Academy, 1997-2000 Degree Course in Social
Practice at Marc Bloch University Strasbourg and
Linz, graduated with the Diplômé des Hautes
Etudes des Pratiques Sociales; professional
experience: 1975-79 apprenticeship as machinist
at Voest Alpine, 1979-1986 skilled worker, 19862008 secretary of the Austrian Metalworkers,
Miners and Energy Supply Workers Trade Union,
2005-08 Chairman of the Upper Austrian Regional
Health Insurance Fund, since 2008 Austrian
Minister of Health.
Richard Sullivan, Prof. MD PhD (1968), British;
former Executive Director of Clinical Centres &
Programmes at Cancer Research UK; since 2008
Professor at London School of Economics; in this
capacity a special advisor to the Director of the
Virunga National Park, DR Congo; Consultant to
Kings College Integrated Cancer Centre and a
member of the Centre’s Executive Board; Chair of
the European Cancer Research Managers Forum
(ECRM); in 2008 the chair of the cancer research
arm of the Slovenian Presidency Fighting Against
Cancer Today (FACT) initiative; author of
18
numerous publications in the fields of cancer
research, biomedical policy and ancient history.
Policy Forum Methods Steering Group on role of
surrogate outcomes in HTA (1999-present).
Tamas Suto, MD, PhD, MICR (1968), Hungarian;
Medicine, Biochemistry; Executive Medical
Director of International Clinical Development and
International Therapeutic Area Head for
Haematology/Oncology at Amgen; a graduate of
the Semmelweis University Medical School in
Budapest and University College London;
member of leading professional organisations
including the Institute of Clinical Research,
European Society for Medical Oncology,
American Society of Clinical Oncology, American
Society of Hematology, European Hematology
Association, and the American Association for
Cancer Research; taught Internal Medicine,
Pathophysiology,
and
Clinical
Chemistry;
developed a novel concept of glomerular selfdefence and discovered the renal metabolism of
Endothelium Derived Relaxing Factor/nitric oxide;
former visiting professor at the West Virginia
University, Morgantown, USA.
Jenny Telander, International Relations Officer,
Unit of International Affairs, Swedish National
Institute of Public Health; Young Gasteiner.
Erzsébet Szöllösi, (1957) Hungarian; advocate
activist with disability for disabled persons’ rights,
rehabilitation engineer, leader of disability
movement from grassroot to European level: VicePresident of the European Disability Forum, Vicepresident of the National Federation of Persons
with Physical Disability, Board member of the
National Council of People with Disabilities, Board
member of the Foundation „Bice-Bóca” for
Children with Physical Disabilities, President of
the Association of People with Physical
Disabilities, Budapest, Vice-President of Public
Foundation of Equal Opportunities for Persons
with Disabilities in Hungary.
Rod Taylor, Dr. (1960), British; Biostatistics,
health services research and health technology
assessment; Associate Professor in Health
Services Research at and Scientific Director of the
Peninsula Clinical Trials Unit, Peninsula College
of Medicine & Dentistry at Universities of Exeter &
Plymouth in UK; PhD clinical physiology
(Glasgow), MSc. in medical statistics (London),
Postgraduate Diploma in health economics
(Aberdeen); 1999 to 2001 first Director of
Appraisals at National Institute for Health and
Clinical Excellence (NICE); Member of NICE
Health Technology Appraisal Committee (2006present), member of NICE Interventional
Procedures Advisory Committee (IPAC) (2008present), member of UK Cochrane Centre
Advisory Board (2000-present), co-chair of HTAi
Christoph Thalheim, (1952), German; spent the
first part of his professional life in the German
Airforce, where he got his university degree in;
after a sabbatical year he set up and run the EUliaison office in Brussels of a major international
NGO focussing on intercultural learning and
international youth exchange programmes for 10
years. From 2000 on he started his work as EU
affairs consultant, working mainly as Secretary
General of the European Multiple Sclerosis
Platform (EMSP), the European Advocacy Group
representing today the interests of 34 national MS
Societies and more than 500.000 people affected
by MS. From 2000 to 2008 EMSP has become
one of the key players in European patient
advocacy, with member organisations in 33
European countries, 12 sustainable industry
partners, several successful projects co-funded by
the European Commission and other donors.
Today, EMSP has excellent working relations to
DG SANCO, DG Enterprise, and DG Employment
as well as to Members and senior staff of the
European Parliament, has a seat in several
European Think Tanks and Working Groups (incl.
the Management Board of EMEA) and supports
its 34 national member organisations by training,
information and lobbying initiatives and tools,
meant to improve continuously the quality of life of
people with Multiple Sclerosis and their care
givers and families.
Eva Turk, Mag., MBA (1978), Slovene;
Researcher in the field of health systems and
health services research at the National Institute
of Public Health in Slovenia; Master of Economics
and Business Administration from Vienna
University
of
Economics
and
Business
Administration (2003). Postgraduate Diploma
(2005) in Hospital Management and MBA (2007)
in Health care Management; cand. PhD (Social
policy); Acted as the focal point for the DG Sanco
co-funded project EUnetHTA for Slovenia.
Appointed by the MoH for representing Slovenia
for JA HTA. Within the FP6, involved in the
Europe for Patients project on Cross border care
in EU. In the field of Long term care and Ageing,
involved in the Healthy Ageing project, Age
friendly cities and currently works on the FP7
project INTERLINKS. Core member of the project
group working on the implementation of Health
19
Accounts in Slovenia and is involved in
implementation and development of Health
Technology Assessment (HTA) in Slovenia. In
2007 received a scholarship for the EHFG and is
since then the Task force member for the Young
Gastein. Memberships: HTAi, ISPOR, EHFG
Young Gastein.
Denny Vågerö, Prof. (1944), Sweden; Professor,
Stockholm University; MSc in Medical Sociology,
PhD in Epidemology; Member of the Royal
Swedish Academy of Sciences, former director of
CHESS, Centre for Health Equity Studies and
member of the Commission on Social
Determinants of Health; his research activities
focus on health inequalities.
Rudi Van Dam; works as a social policy expert at
the Belgian Federal Public Service Social
Security.
He
Coordinates
the
Belgian
representation in the Indicator Subgroup of the
Social Protection Committee. At the national level
he coordinates a working group on social
protection and social inclusion indicators and is
responsible for the indicator and analysis part of
the National Strategic Report Social Protection
and Social Inclusion. Furthermore he takes part
in the steering committee of a project to establish
a Belgian health monitoring system. Before
entering his current position he worked as a
senior researcher in social policy issues at the
University of Antwerp.
Stephan Van den Broucke; Associate Professor
at the Department of International Health, Faculty
of Health, Medicine and Life Sciences of
Maastricht University, The Netherlands. He
teaches in the Bachelor and Master programs of
European Public Health in Maastricht and the
Master program in Psychology at the KU Leuven,
Belgium, and has been a guest lecturer at various
universities and institutes in Europe. Formerly a
senior expert at the Flemish Institute for Health
Promotion in Brussels and a project officer at the
Executive Agency for Health and Consumers of
the European Commission in Luxembourg, he has
coordinated and supervised a series of national
and international research projects in the areas of
health promotion planning and evaluation, mental
health promotion, health inequalities, capacity
building and health literacy. He serves as an
expert adviser to the European Commission’s
Health and Research Directorate Generals and as
a technical adviser for the World Health
Organisation, and is a member of the executive
team of the Regional Committee for Europe of the
International Union for Health Promotion and
Education (IUHPE). He holds a Ph.D. in
Psychology (KU Leuven) and a degree in
Complementary Studies in Health Policy
(University of Antwerp), and is author or co-author
of more than 50 peer-reviewed international
publications and author and editor of several
books. His main research focus is on program and
project
management,
evaluation,
quality
assurance and capacity building in public health
and health promotion, with a specific focus on
European public health.
Jan Van Emelen, Dr. (1951), Belgian; 1968-1975
Medical Doctor Catholic University Leuven,197475 Tropical Medicine (Royal Institute of Tropical
Medecin Antwerp); 1991-94 Specialisation –
Master in Occupational health; 2001 INSEAD
management: European Health Care Leadership;
since 2003 Director Research&Innovation of
MLOZ – Independent Health Insurance Funds,
president working group Disease Management
within AIM; 1999-2003 Expert Public health and
social security – advisor of the Belgian Prime
Minister Guy Verhofstadt, Minister Rik Daems,
senator Jan Remans; 1990-99 Medical inspector
– Belgian Ministry of Labour; 1976-1990 Medical
Doctor in the Belgian Development Cooperation
Program; 1975-76 Researcher at Royal Institute
of Tropical Medecin Antwerp.
Ewout van Ginneken, Dr. (1976), Dutch; health
care systems, health financing, cross-border
healthcare, pharmaceutical policy; Head of the
Unit Health Systems and Policies at the Berlin
University of Technology’s Department of Health
Care Management, WHO Collaborating Centre for
Health Systems, Research and Management;
Honorary research fellow of the European
Observatory on Health Systems and Policies;
Master’s of Health Sciences, Health Policy and
Administration, Maastricht University and PhD in
Public Health, Berlin University of Technology.
Myria Vassiliadou; Secretary General, European
Women’s Lobby.
Androulla
Health.
Vassiliou;
EU
Commissioner for
Zeger
Vercouteren,
Executive
Director,
Government Affairs & Policy, Johnson & Johnson.
Till Voigtländer, Dr. (1964), German; Consultant
for Neurobiology, Resident in Neuropathology,
Neurosciences; Head of the Laboratory for
Clinical Neurochemistry and Neuroimmunology,
Institute of Neurology, Medical University of
20
Vienna; Country coordinator of Orphanet (The
European Portal for Rare Diseases) in Austria,
Head of the subcommittee for rare diseases at the
highest advisory board of the Austrian Ministry of
Health; member of the Austrian Association for
Neuropathology, member of the management
board of Orphanet.
Sector. Since March 2009 he was additionally
given the responsibility to enhance the CRM
culture within the Workflow and Solutions Division
of Siemens Healthcare. In April 2007, he became
President of COCIR, the European Association of
the Radiological, Electromedical and HealthcareIT industry.
Liisa-Maria Voipio-Pulkki, MD PhD (1955),
Finland; Senior Medical Adviser of the Association
of Finnish Local and Regional Authorities,
positioned in Helsinki; Adjunct Professor of
Medicine, University of Turku, Finland. Member of
the President´s Committee, HOPE. Specialist in
internal medicine and cardiology. Formerly Chief
of Emergency and Acute Care, Helsinki University
Central Hospital and Chair of the CPD Committee,
Finnish Medical Association Duodecim.
Svetlana Vukajlovic; Director General of the
Republic Institute for Health Insurance (national
public insurance); prior to the function she held
the function of the General Manager of two
biggest private insurance companies in Serbia,
Zepter and Delta Insurance Company. Mrs.
Vukajlovic is the first female head of insurance
company in Serbia and the first female general
director of the Republic Institute for Health
Insurance in its 60–year long history. The
common denominator for all the functions she
held are great and recognizable results.
Lawrence von Karsa, Dr. (1953), American;
medical doctor and specialist in health care
planning, programme implementation and quality
assurance; Head, Quality Assurance Group in the
Section of Early Detection and Prevention at the
International Agency for Research on Cancer
(IARC) in Lyon, France; responsibilities include
coordination of the European Cancer Network
(ECN) for Screening and Prevention in which the
European Breast, Cervical and Colorectal Cancer
Screening networks established under the Europe
Against Cancer Programmes and the EU Health
Programme have been consolidated, and
coordination of the European Cooperation and for
development and implementation of Cancer
screening and prevention Guidelines (ECCG)
project in which the EU Breast and Cervical
Screening quality assurance guidelines are
currently being updated and expanded to include
recommendations
on
HPV
testing
and
vaccination.
Heinrich von Wulfen; studied Electrical
Engineering at the Technical University of
Braunschweig. In 1983, he joined the Siemens
Medical Engineering Group. In 1992, he became
Head of Siemens Medical Systems, USA,
Magnetic Resonance Division. From 1997 to
2001, he was Head of the German Northern
Region Medical Engineering Group, Hamburg.
From 2001 to 2004, he was responsible for
Siemens Ltd. Medical Solutions in Bombay, India.
He became President of Medical Solutions
Asia/Pacific in 2004 and has been President of
European Sales & Service of Siemens Medical
Solutions Europe since December 2006. In May
2008 he was appointed Regional CEO Europe,
Africa and Middle East of the Siemens Healthcare
Kieran Walshe, Prof. (1964), British; academic,
public policy and management; professor of
health policy and management at Manchester
Business School, and director of the Institute of
Health Sciences, University of Manchester;
director of the NIHR (National Institute for Health
Research) service delivery and organisation
research programme, and scientific committee
chair and board member, European Health
Management Association.
Michael Wilks, Dr. (1949), British; family doctor
from 1977 to 1992, now specialises in clinical
forensic medicine. President of the Standing
Committee of European Doctors (CPME) and past
Chairman of its ethics committee. Chairman of the
British Medical Association’s Representative Body
and of its Me
dical Ethics Committee (1997-2006). Active in the
creation of the BMA service for the support of
doctors with health problems. Trustee of the Sick
Doctors Trust, and chairman of the Rehabilitation
of Addicted Prisoners Trust, both charities active
in addiction treatment.
Susan Williams; Head of International Affairs,
International Department, Royal College of
Nursing (since 2005), she oversees a small team
which coordinates the RCN’s European and
international representational, campaigning and
development work. She joined the RCN in 1995
as European Officer focusing on expanding the
RCN’s influence on EU policies and proposals
impacting on health. Prior to that Susan worked
as a European Policy Officer in the international
21
arm of the local authority associations in the UK,
the Local Government International Bureau.
Matthias Wismar, Dr.; Senior Health Policy
Analyst, European Observatory on Health
Systems and Policies.
Ingrid Wolfe, Dr. (1966) UK, USA; Paediatrics
and Child Public Health; Research fellow London
School Hygiene Tropical Medicine, Paediatrician
Whittington Hospital, London. Researching
European children’s health services and systems.
Contributory memberships of Royal College
Paediatrics and Child Health’s health services
research project “Modelling the Future”,
Healthcare for London’s expert advisory
committee on children’s health services, National
Collaborative for Children’s Integrated Healthcare.
Harold (Hal) Wolman, Prof. Dr.; Director of the
George Washington Institute of Public Policy and
Professor of Political Science and Public Policy at
the George Washington University in Washington,
DC. His research interests and publications are in
the areas of urban policy, comparative public
policy, policy innovation and policy transfer.
Stephen Wright, (1953), British; economist;
presently Executive Director European Centre for
Health Assets and Architecture (past Associate
Director Human Capital, European Investment
Bank). B.Sc. (Econ.) with Honours in Economics
and Geography, University College London and
M.Litt. in the Economics of Natural Resources,
Kings College Aberdeen.
Founder Steering
Committee member of the European Observatory
on Health Systems and Policies; past Board
Member and Treasurer of the European Health
Property Network; and Steering Committee
Member
of
the
Sustainable
Healthcare
Programme, Member of the International Health
Economics Association, Editor and author of
several chapters in European Observatory books
Investing in Hospitals of the Future and Capital
Investment for Health.
and economic development. His work experience
covers Africa, Asia, Europe, and the Middle East.
He has authored five books, the most recent is
“Attaching Inequality in the Health Sector” (2009).
Miodrag Zaric, Dipl. Ing.; President of Holywell
Neopren, founder of Centre for Hyperbaric
Medicine, co-founder of International School for
Baromedicine on University of Belgrade School of
Medicine, founder of the Laboratory for
fundamental research in hyperbaric medicine on
Institute of Medical Physiology University of
Belgrade School of Medicine.
Friedrich Zettinig, (1948) Austrian; Mayor of Bad
Hofgastein;
education
and
gastronomy
apprenticeship in Bad Hofgastein, certified ski
instructor, ÖSV (Austrian Ski Association) trainer,
hiking guide and bio trainer; international working
experience as trainer and ski instructor (e.g. USA
and Australia); spokesman for sports and events
of the Spa & Tourist Office Bad Hofgastein; more
than 20 years he headed the local ski school and
was president of the ski club, in this function he
organised and realised numerous regional,
national and international ski competitions; since
2004 he is local councillor, 2008 he became vicemayor and since March 2009 he is elected Mayor
of Bad Hofgastein.
Alexandra Wyke, Dr.; Chief Executive Officer,
Patient View.
Abdo Yazbeck; Health Sector Manager for the
Europe and Central Asia Department of the World
Bank. Prior to this position, he was the Program
Leader for the Health and AIDS sector at the
World Bank Institute (the capacity building arm of
the World Bank). He has a Ph.D. in Economics
with a focus on Health and Labor and has over 20
years of experience in the areas of health policy
22